Rohan Lathia currently serves as Senior Director of Business Development and Market Insights at Upstream Bio since December 2022. Previously, Rohan held the position of Senior Director of Business Development at Radius Health, Inc., where notable achievements included leading the sale of the company for $890M and securing worldwide rights for a SIK 2/3 inhibitor program. Rohan's experience extends to Biogen, where as Associate Director, responsibilities included delivering financial analyses on M&A opportunities and collaborating on significant deals exceeding $5B in total value. Earlier professional roles include consulting at Bain & Company and various internships in product development and research. Rohan's educational background includes an MBA in Finance from MIT Sloan School of Management, a Master's in Engineering Management from Dartmouth College, and a Bachelor's in Biomedical Engineering from Case Western Reserve University. Recognized with multiple awards for contributions to project excellence, Rohan brings extensive expertise in business development within the life sciences sector.